Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Wondering about your retirement target at 40? Discover how to plan ahead for a secure financial future with our expert insights.
24,965 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Opendoor and Offerpad led a narrow iBuyer rally with midday gains of about 7% and 6%, respectively. The move comes as...
Rackspace Technology posts a tighter loss and higher 2026 profit outlook after a solid Q4, even as shares slip follow...
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...
U.S. equities moved higher on Thursday as a wave of fresh Wall Street analyst calls buoyed major names across healthc...
Trad.Fi and W3 unveil a four-year plan to put a $650 million private-credit pipeline on blockchain rails, aiming to c...
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
Bitcoin remains above $66,000 as March begins, with analysts weighing a bitcoin high-stakes march: $120k scenario ami...
ARK Invest placed a sizable bet on Circle amid a sell-off triggered by draft Clarity Act provisions. The move sparked...
ProShares Ultra Silver aimed to double silver's move, but daily resets and volatility trimmed returns, reshaping expe...
Lam Research surged about 21% from its June trough as markets priced in a slower path for rate hikes. This report wei...
A fresh AI memory stock is gaining momentum as hyperscalers scramble for high-bandwidth memory. Analysts say it could...